DIANE RUSSELL: Open Payments
NPI 1457994089 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$724 in 36 payments from 13 companies in 2025. Trend: 2023 $822 · 2024 $1,057 · 2025 $724
Food & beverage: $724
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $152 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| Philips North America LLC | 3 | $70 |
| Amgen Inc. | 3 | $64 |
| PFIZER INC. | 3 | $64 |
| Abbott Laboratories | 3 | $64 |
| Boston Scientific Corporation | 3 | $52 |
| HEARTFLOW, INC. | 1 | $28 |
| CVRx, Inc. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: CAMZYOS, LEQVIO, REPATHA, VYNDAQEL, WATCHMAN FLX, Ambulatory Monitoring & Diagnostics Undivided, AVEIR, FFRct.
Industry payments across UT — which companies pay providers there.
